New medicine supply notices
- admin82291
- 4h
- 2 min read
Iloprost (Vebulis) nebulisers (Pharmacode: 2643006) Supplies of Vebulis iloprost nebulisers are low throughout New Zealand. An unapproved alternative was listed from 9 February. Details and a patient flyer are available.
Updated medicine supply notices
Concerta: 27 mg out of stock, limited supply of 18 and 36 mg, 54 mg available
Ritalin: All strengths available
Rubifen: All strengths available
Sandoz XR: All strengths available
Teva: All strengths available, may be limited availability of 36 mg in some places.
Diasip | Vanilla flavour (Pharmacode 2702061)
GMPro Ultra Lemonade (Pharmacode: 2657201).
MSUD Lophlex LQ 20 (Pharmacodes: 2683016 and 2711451)
PKU Lophlex powder | Orange flavour (Pharmacode: 2593890)
Renilon | Apricot flavour (Pharmacode 2439379)
Varenicline (changing from Champix to Pharmacor) There has been a delay to the arrival of the Pharmacor brand of varenicline products. They now expected in March 2026. We are looking at moving out the delisting date for Champix.
Resolved issues
none
Note: Supply issues are marked as resolved when the supplier has product available. It can take another 1 to 2 weeks for stock to reach pharmacies around the motu.
Consultations & Notifications
Proposal to widen access to Trikafta and Kalydeco and fund Alyftrek for the treatment of cystic fibrosis (Consultation closes: 11 February)
Proposal to widen access to brentuximab vedotin for the treatment of systemic anaplastic large cell lymphoma (consultation closes 19 February 2026)
Monthly updates